<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 C:\PWang\Datasets\grobid-0.5.5\grobid-0.5.5\grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.5.5" ident="GROBID" when="2020-06-22T14:04+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Asger</forename><surname>Bjerregaard</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Telethon Kids Institute</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">School of Paediatrics &amp; Child Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Ingrid</forename><forename type="middle">A</forename><surname>Laing</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Telethon Kids Institute</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">School of Paediatrics &amp; Child Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>BSc</roleName><forename type="first">Nadia</forename><surname>Poulsen</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Telethon Kids Institute</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">School of Paediatrics &amp; Child Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD, DMSc</roleName><forename type="first">Vibeke</forename><surname>Backer</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD, PhD</roleName><forename type="first">Asger</forename><surname>Sverrild</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Markus</forename><surname>Fally</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Siew-Kim</forename><surname>Khoo</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Bsci</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Telethon Kids Institute</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">School of Paediatrics &amp; Child Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Lucy</forename><surname>Barrett</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute for Respiratory Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Svetlana</forename><surname>Baltic</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute for Respiratory Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>FRACP</roleName><forename type="first">Philip</forename><forename type="middle">J</forename><surname>Thompson</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Institute for Respiratory Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Glenys</forename><surname>Chidlow</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Microbiology</orgName>
								<orgName type="institution">PathWest Laboratory Medicine WA</orgName>
								<address>
									<settlement>Nedlands</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MS</roleName><forename type="first">Chisha</forename><surname>Sikazwe</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Microbiology</orgName>
								<orgName type="institution">PathWest Laboratory Medicine WA</orgName>
								<address>
									<settlement>Nedlands</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">School of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MBBS</roleName><forename type="first">David</forename><forename type="middle">W</forename><surname>Smith</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution">Telethon Kids Institute</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Microbiology</orgName>
								<orgName type="institution">PathWest Laboratory Medicine WA</orgName>
								<address>
									<settlement>Nedlands</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">School of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Yury</forename><forename type="middle">A</forename><surname>Bochkov</surname></persName>
							<affiliation key="aff6">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">School of Medicine and Public Health</orgName>
								<orgName type="institution">University of Wisconsin</orgName>
								<address>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>FRACP</roleName><forename type="first">Peter</forename><surname>Le Souëf</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">School of Paediatrics &amp; Child Health</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<settlement>Perth</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD, PhD</roleName><forename type="first">Celeste</forename><surname>Porsbjerg</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Respiratory Research Unit</orgName>
								<orgName type="institution">Bispebjerg University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.rmed.2016.12.010</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abstract</head><p>Background-In experimental studies viral infections have been shown to induce type 2 inflammation in asthmatics, but whether this is a feature of naturally occurring virus-induced asthma exacerbations is unknown. Thymic stromal lymphopoietin (TSLP) released from the airway epithelium in response to damage, has been suggested as a link between viral infection and type 2 inflammation, but the role of TSLP in asthma exacerbations is unknown.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>With an estimated prevalence of nearly 10%, asthma is one of the more frequent chronic diseases in Western countries, and exacerbations are the major cause of morbidity and health care utilization <ref type="bibr" target="#b0">[1]</ref>. Respiratory viruses are one of the most common triggers of asthma exacerbations <ref type="bibr" target="#b1">[2]</ref>, but the underlying mechanisms are not fully understood.</p><p>Overall, around half of asthma patients have prominent type 2 inflammation during stable disease <ref type="bibr" target="#b2">[3]</ref>, characterized by IL-5 driven eosinophilia in both sputum and blood and mucus hypersecretion, airway hyperresponsiveness and increased IgE production, driven by IL-4 and IL-13. This Th2-high phenotype has been associated with more severe disease <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b4">5]</ref> and an increased risk of exacerbations <ref type="bibr" target="#b5">[6]</ref>. Whether aggravated type 2 inflammation is a feature of both virus-induced and non-viral exacerbations, is currently unknown and is likely to have implications for the efficacy of emerging biological treatment in reducing the rate and severity of these exacerbations.</p><p>Allergen sensitization and exposure is the established cause of increased type 2 inflammation. However, in vitro studies have suggested that respiratory viruses are capable of independently inducing type 2 inflammation, by causing a release of pro-inflammatory cytokines, including thymic stromal lymphopoietin (TSLP), from the airway epithelium <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref>. In this innate immune pathway, TSLP causes release of type 2 cytokines IL-4, IL-5 and IL-13, from T-cells through activation of dendritic cells <ref type="bibr" target="#b8">[9]</ref> and by direct action on innate lymphoid cells (ILC) <ref type="bibr" target="#b9">[10]</ref>. TSLP is increased in patients with asthma, compared to controls <ref type="bibr" target="#b10">[11]</ref> and anti-TSLP antibodies have been shown to reduce airway inflammation in response to an allergen provocation test <ref type="bibr" target="#b11">[12]</ref>. Epithelial cells from asthmatics seem to be particular prone to TSLP release following exposure to viral infection in vitro <ref type="bibr" target="#b7">[8]</ref> but whether TSLP is induced in asthmatics during viral infection in vivo and stimulates type 2 inflammation is unknown.</p><p>Asthma patients, particularly those with type 2 inflammation, experience more severe symptoms when experimentally infected with respiratory viruses <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref> and, although controversial, the mechanism is proposed to involve a reduced production of interferons <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>. Whether patients with high type 2 inflammation during a real-life viral infection experience more severe exacerbations, is unclear.</p><p>The aim of the present study was to test the hypothesis that sputum eosinophilia and increased FeNO are features of naturally occurring virus-induced exacerbations. Secondarily, that the level of sputum eosinophilia and FeNO are associated with the degree of TSLP expression in sputum. Finally we wished to test whether any type 2 inflammation during a virus-induced exacerbation would be associated with more severe exacerbations, measured by FEV1. Exploratory outcomes included rhinovirus subtype and systemic markers of inflammation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p>The study was a prospective observational study conducted at Bispebjerg University Hospital between July 2013 and September 2015. Patients were recruited both from the hospital Emergency Department, and from the acute asthma clinic within the hospital research unit and were seen within 24 hours of contact. Exacerbations were defined as worsening of symptoms surpassing the daily variation that required a change in treatment in line with ERS/ATS recommendations <ref type="bibr" target="#b18">[19]</ref>. After 4 weeks, participants were re-examined in the research unit. All patients had a doctor's diagnosis of asthma and had the diagnosis confirmed during the study in line with GINA recommendations <ref type="bibr" target="#b0">[1]</ref>. Patients were between 16 and 45 years of age. Pregnant women and patients with pulmonary diseases other than asthma were excluded. Both current and past smokers were included.</p><p>The study was approved by the local scientific ethics committee (protocols nr: H-2-2013-046, H-3-2011-121, H-15003691).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Examinations</head><p>Fractional expiratory nitric oxide (FeNO) (NioxMinor, Aerocrine, Sweden) was assessed following the recommendations of the ERS and ATS <ref type="bibr" target="#b19">[20]</ref> to use the mean of two measurements. Patients completed spirometry (EasyOne, NDD, Switzerland) according to ERS guidelines <ref type="bibr" target="#b20">[21]</ref>, using NHANES III for lung function predicted values <ref type="bibr" target="#b21">[22]</ref>. Because patients were examined during an exacerbation, they were not asked to withhold beta-2-agonists prior to spirometry, but the time since the last dose of reliever was taken was recorded. Induced sputum was processed as described by Pavord et al <ref type="bibr" target="#b22">[23]</ref>: In brief, after inhalation of 1 mg terbutaline, sputum was induced by inhalation of hypertonic saline in increasing concentrations (3%, 4%, and 5%) for 5 minutes each (total duration 15 minutes). Sputum plugs were selected and processed, cytospins were prepared, and a differential cell count of 400 non-squamous cells was completed. The hospital clinical laboratory completed a full white blood cell differential count and measured high-sensitivity C-reactive protein (hsCRP), total IgE and specific IgE to common allergens (grasses, house dust mite, birch, mugwort, dog, cat, horse, Cladosporium herbarum and Alternaria tenuis). Atopy was defined as the presence of specific IgE (&gt;0.35 IU/ml) to one or more of these allergens. Asthma control was assessed with the 5-item Asthma Control Questionnaire (ACQ) <ref type="bibr" target="#b23">[24]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Detection of respiratory pathogens</head><p>Flocked nasal swabs (Copan, Italy) were used to sample turbinate nasal. Samples were assessed for human adenovirus species B-D; human bocavirus; coronaviruses OC43, 229E, HKU1 and NL63; influenza viruses A, B and C; parainfluenzaviruses 1 -4; KI and WU polyomaviruses; respiratory syncytial virus types A and B and human metapneumovirus, using a tandem multiplex real-time PCR assay. <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref> A PCR directed at picornavirus sequences in the 5′UTR was used to detect RV. The products were identified to species level as RV-A, RV-B or RV-C by sequencing of this 260bp product and analysed using ClustalX software <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b27">28]</ref>. The local hospital laboratory at Bispebjerg Hospital completed bacterial cultures on spontaneous expectorates collected during the exacerbation <ref type="bibr" target="#b28">[29]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantification of TSLP mRNA expression</head><p>Sputum cell pellets were stored in RNAlater (Ambion, USA) and kept at −80°C until processing. RNeasy Mini kit (Invitrogen, USA) was used to extract mRNA following the manufacturers recommendations. After the RNA extraction, cDNA was synthesised using SSIII reverse transcriptase (Invitrogen, USA) as described by the manufacturer. TSLP was quantified using digital droplet PCR (QX200, Bio-Rad, USA) with TaqMan primers ands probes. GAPDH was used for normalization. For the analyses participants were divided into TSLP high and TSLP low by the median expression.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p>The data was analysed with SPSS version 22.0 (IBM SPSS, USA). Normally distributed data are reported as mean ± standard deviation and analysed using students t-test for continuous variables, and chi-squared test for categorical variables. Log-transformed variables are reported as geometric mean (GM) with 95% CI. For log-transformation of sputum eosinophil percentage, cases with 0% were set to 0.1% prior to transformation. Nonnormally distributed data are reported as median (range) and comparisons are made using the Mann-Whitney U-test. Regarding TSLP, we used the median expression to classify patients as either TSLP-high (above the median) or TSLP-low (below the median) at exacerbation.</p><p>A multiple linear regression model, stratified by virus detection, was used to examine determinants of FEV1 %-predicted at the time of exacerbation. Due to multicollinearity each inflammatory marker was assessed separately with adjustment for predefined covariates: gender, age, smoking, bacterial infection and ICS usage. For all analyses a p-value of &lt;0.05 was considered significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Respiratory viruses and bacteria detected at exacerbation</head><p>A total of 88 patients were included in the study, of which 44 (50%) had a detectable respiratory virus at exacerbation. Viruses detected were rhinovirus (77%), human coronavirus (16%), parainfluenza virus (5%) and human metapneumovirus (2%) (figure 1). Among patients with a respiratory virus, six had a bacterial co-infection (3 H. influenzae, 1 S. pneumoniae, 1 S. aureus and 1 M. catarrhalis). There were three patients with bacterial infections in the virus-negative group (2 S. pneumoniae and 1 Gemella haemolysans) (p=0.29). In the comparisons of virus-positive and negative groups, the nine patients with bacterial infections were included. All conclusions remained unchanged when patients with bacterial infections were excluded from the analyses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical characteristics of virus-positive vs. virus-negative patients</head><p>Demographics of patients with, or without, viral infection were similar, as were the level of treatment required at exacerbation <ref type="table" target="#tab_1">(table 1)</ref>. Likewise, lung function and inflammatory markers were largely similar, with the exception of a higher CRP in the virus-positive group (GM 8.4, 95% CI 3.5-11.5, p=0.02) compared to the virus-negative group (GM 4.9, 95% CI 3.5-7.0). Sputum induction was successful in 67 patients (76%, 31 without virus and 36 with virus). The absolute number of both eosinophils and neutrophils were higher in viruspositive patients, compared to virus-negative patients, but the percentages of each cell type were not different between virus-positive and negative <ref type="table" target="#tab_1">(table 1)</ref>. Consequently, the distribution of patients into established sputum phenotypes <ref type="bibr" target="#b29">[30]</ref> was similar between viral and non-viral exacerbations (figure 2).</p><p>In the virus-induced group FeNO was higher at exacerbation (GM 28, 95% CI 22-35, p=0.001) compared to follow-up (GM 18, 95% CI 14-24), which was also the case in the non-viral group (GM 35, 95% CI 26-49 vs. 23, 95% CI 18-30, respectively, p=0.001). Sputum eosinophils were not significantly different at follow-up compared to the percentages during exacerbation in either group.</p><p>In the period between the initial and the follow-up visit patients were treated following clinical guidelines (GINA). Following admission 75% recieved an oral course of prednisolone (37.5 mg once daily for 10 days), while the rest were managed by increasing their inhaled steroid. No other treatment was initiated by the study team, but existing treatment with LABA, leukotrienes or any other asthma medication was continued following exacerbation. There were no significant differences in clinical management between the virus-positive and virus-negative group.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TSLP mRNA expression</head><p>There was no difference in sputum TSLP mRNA expression between patients with, or without, a viral infection at exacerbation (GM 3.2, 95% CI 1.4-7.1 vs. 3.5, 95% CI 2.0-6.0, respectively, p=0.84) (figure 3). In all, there were 36 paired measurements of TSLP (exacerbation and follow-up; 19 from virus-positive patients, 17 from virus-negative patients). In virus-positive patients TSLP expression was lower at exacerbation (GM 2.8, 95% CI 1.2-6.8, p=0.03) compared to follow-up (GM 6.1, 95% CI 2.8-13.4), whereas there was no difference between exacerbation (GM 2.8, 95% CI 1.1-7.0, p=0.74) and follow-up (GM 2.4, 95% CI 0.9-6.4) in the virus-negative group (figure 3).</p><p>In patients without a virus infection, there was no difference in inflammatory phenotype, FEV1 or ACQ between those with high or low TSLP expression (n=12 and n=9, respectively) (figure 4). However, in virus-positive patients, those with high TSLP expression levels (n=15) had significantly lower sputum eosinophil percentage (GM 0.5, 95% CI 0.2-1.4, p=0.01 vs. 3.8, 95% CI 1.1-13.8), higher FEV1 (86.  <ref type="figure" target="#fig_3">figure 4</ref>). There was no difference in ICS usage between the TSLP high and low groups.</p><note type="other">2±12.4, p=0.03 vs. 75.1±14.9), lower ACQ score (2.5±1.2, p=0.01 vs. 3.7±1.4), higher blood neutrophils (</note></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Type 2 inflammation and FEV1 at exacerbation</head><p>To examine the impact of type 2 inflammation on the clinical severity of exacerbation, the association with sputum eosinophils, FeNO and FEV1 at exacerbation was examined in both the virus-positive and negative group. The percentage of sputum eosinophils correlated negatively with FEV1 in patients with a virus detected at exacerbation (rho −0.42, p=0.01) and in patients with non-viral exacerbation (rho −0.60, p&lt;0.001). When adjusted for gender, age, smoking status, bacterial infection and ICS usage in a multiple linear regression, the associations remained significant (p=0.05 and p=0.02, respectively) (table 4). In univariate analyses FeNO was negatively correlated with FEV1 in the virus-positive group (rho −0.37, p=0.01) but not significantly associated with FEV1 in virus-negative patients (rho −0.23, p=0.13). After adjustment for the same potential confounders, the association remained significant in the virus-positive group (p=0.02), yet not in the virus-negative group (p=0.98) (table 4).</p><p>As exploratory predictors of FEV1, we also measured blood eosinophils, total IgE and sputum neutrophils. Using the same analysis, both blood eosinophils and total IgE were associated with FEV1 with no difference between virus-positive and negative patients, while sputum neutrophils were not associated with FEV1 in either group (data not shown).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact of the type of virus detected</head><p>Patients infected with a rhinovirus had lower %-predicted FEV1 at exacerbation (77.2±16.0, p=0.02) compared to patients with other respiratory viruses (90.8±15.5), and a higher ACQ score (3.4±1.4, p=0.03 vs. 2.3±1.4, respectively) (table 2). There were no significant differences in demographics, spirometry or inflammatory markers between patients infected with RV-C (n=10) compared to patients infected with RV-A (n=23) (table 3).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In this study, type 2 inflammation and TSLP mRNA expression were present in virusinduced exacerbations to a similar extent as in non-viral exacerbations. Furthermore, both sputum eosinophils and FeNO were negatively correlated with FEV1 at exacerbation.</p><p>To our knowledge, this is the first report on TSLP mRNA expression during naturally occurring asthma exacerbations. In contrast to our hypothesis, we found that participants with high sputum TSLP had lower sputum eosinophils, lower FeNO and higher %FEV1 at exacerbation than participants with low sputum TSLP suggesting that TSLP does not promote type 2 inflammation in the airways during virus-induced exacerbations of asthma. It is possible that the timing of sample collection and changes in post-translational modification of the TSLP mRNA could have impacted on the final amount of TSLP protein being produced, although, previous studies have found good concordance between TSLP gene expression and protein concentration <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b30">31]</ref>. An inhibitory effect of corticosteroids cannot be ruled out, but it would not explain the difference between the virus-positive and virus-negative group. Although ex vivo studies have proposed that TSLP acts as a mediator of eosinophilia in response to viral infection <ref type="bibr" target="#b31">[32]</ref>, this has not been documented in vivo. Our findings suggests that this effect might be more complex in the setting of asthma exacerbations and suggests that other pathways (e.g. IL-33 or other modulators of ILC2s) in the innate immune system are contributing to initiating type 2 inflammation in response to viral infection.</p><p>We attempted to measure TSLP protein using a highly sensitive ELISA (Bio-Plex Pro, BioRad on a Luminex platform, lower limit of detection 0.8 pg/ml) but did not detect TSLP in any of the samples. This may have been due to the addition of dithiothreitol (DTT) to the sputum samples as part of the standard method for sputum sample processing, since DTT is known to alter the tertiary structure of a number of proteins, and thereby could have interfered with the ELISA <ref type="bibr" target="#b32">[33]</ref>. Unfortunately this could not be determined as no DTT-free samples were available for re-analysis.</p><p>Little has been published on the association between inflammatory phenotype and severity of airway obstruction specifically during virus-induced asthma exacerbations. In the present study, both sputum eosinophils and FeNO negatively correlated with FEV1 in virus-positive patients in line with a recent experimental study <ref type="bibr" target="#b13">[14]</ref>. To eliminate any seasonal impact on inflammatory markers, patients were recruited during all four seasons, however no seasonal differences in inflammatory markers at exacerbation were observed. Sensitization and exposure to allergens in conjunction with viral infection has been shown to increase the risk of admission <ref type="bibr" target="#b33">[34]</ref> and biological treatment options targeting type 2 inflammation, have reported reductions in exacerbation rates of 50-80% <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>. Yet, whether predominantly virus-induced exacerbations were being prevented, or non-viral exacerbations, is unknown. It is possible that the inflammatory phenotype expressed during stable disease is representative of the response developed at exacerbation, regardless of trigger. A prospective study of asthma patients phenotyped during stable disease and followed until exacerbation is required to investigate this.</p><p>The mechanisms by which increased type 2 inflammation might negatively affect the course of a virus infection in asthmatics are not clear, but recent mechanistic studies have suggested type 2 inflammatory pathways may lead to reduced production of interferon <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>. The role of type 2 inflammation in relation to naturally occurring viral infections in asthma patients, has been much less examined. Denlinger and colleagues sampled asthma patients with symptoms of a cold, and found that patients who went on to develop a clinical exacerbation were characterized by higher sputum neutrophils, whereas an association with eosinophils or FeNO was not observed. However, it should be noted that the study was not aimed at describing the severity of the exacerbations, and the potential association with sputum inflammatory phenotype <ref type="bibr" target="#b38">[39]</ref>. Wark and colleagues have found that degranulation of both neutrophils and eosinophils was associated with a longer time in hospital for patients admitted with virus-induced acute asthma <ref type="bibr" target="#b39">[40]</ref>. In the present study, sputum neutrophil count, though elevated in virus-positive exacerbations compared to non-viral exacerbations, did not correlate with FEV1.</p><p>More severe wheezing illness have been reported in children infected with RV-C, compared to RV-A <ref type="bibr" target="#b40">[41]</ref>, however, this has not been established in adults <ref type="bibr" target="#b41">[42]</ref>. In the present study, RV-C comprised 30% of all rhinovirus infections -a proportion similar to that reported by Wark and colleagues <ref type="bibr" target="#b42">[43]</ref>. We found no difference in clinical measurements or sputum inflammatory phenotype between patients with RV-C and RV-A. We did note that patients infected with RV-C had higher blood eosinophils at exacerbation that were not mediated by a difference in ICS dose; however, this should be interpreted with caution as no other type 2 markers were increased.</p><p>In conclusion, we have found that type 2 inflammation was present during virus-induced exacerbations to the same extent as non-viral exacerbations, and was associated with a lower FEV1 at exacerbation. Unexpectedly, TSLP expression correlated negatively with sputum eosinophils in virus-induced exacerbations, suggesting that other pathways (including epithelial cytokines such as IL-33) might be responsible for driving innate pathways leading to type 2 inflammation in acute virus induced asthma.  Distribution of sputum inflammatory phenotypes in patients with, or without, detectable virus at exacerbation (n.s.). Paucigranulocytic (&lt; 3% eosinophils &amp; &lt; 61% neutrophils), eosinophilic (≥ 3% eosinophils &amp; &lt; 61% neutrophils), neutrophilic (&lt; 3% eosinophils &amp; ≥ 61% neutrophils), mixed granulocytic (≥ 3% eosinophils &amp; ≥ 61% neutrophils). TSLP mRNA expression in sputum at exacerbation in patients with, or without, viral infection. Normalized to GAPDH = 5000 copies/μl. Inflammatory and clinical characteristics of virus positive patients with TSLP expression at exacerbation below the median (TSLP low) and above the median (TSLP high).  Respir Med. Author manuscript; available in PMC 2018 February 01.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2</head><p>Characteristics of patients at presentation with exacerbation with rhinovirus or other viruses at exacerbation. Sputum total cell count (×10 6 /ml) a  <ref type="table">Table 3</ref> Characteristics of patients infected with rhinovirus A (RV-A) compared with patients infected with rhinovirus C (RV-C).   <ref type="table">Table 4</ref> Multivariate linear regression of sputum eosinophils (a) and FeNO (b) to predict FEV1 %-predicted at the time of an asthma exacerbation, corrected for gender, age, smoking status, bacterial infection and ICS usage. Sputum differential counts were available from 67 patients (31 without virus, 36 with virus). </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RV-A (n=23)</head><note type="other">RV</note></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Prevalence of respiratory viruses at exacerbation (n=44).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc>-transformed and presented as geometric mean (95% CI).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc>-transformed and presented as geometric mean (95% CI).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc>vs. former + current smoker.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><head></head><label></label><figDesc>median 4.3×10 9 cells/L (range 2.3-10.2), p=0.04 vs. 6.0×10 9 cells/L (2.8-13.5)) and a trend for lower FeNO (GM 27 ppb, 95% CI 20-36, p=0.16 vs. 38 ppb 95% CI 26-56) compared to those with low TSLP expression levels (n=15) (</figDesc><table></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="false"><head>Table 1</head><label>1</label><figDesc>Clinical characteristics of patients at presentation with exacerbation with, and without, detectable viral infection.</figDesc><table>No virus detected 
(n=44) 

Virus detected 
(n=44) 

p-value 

Gender (% females) 
61 
68 
0.50 

Age 
34 (10) 
32 (12) 
0.35 

Smokers (% never; former; current) 
59; 14; 27 
75; 11; 14 
0.23 

Packyears (among former and current smokers) 11.7 (11.2) 
6.9 (5.0) 
0.19 

Atopic (%) 
68 
57 
0.27 

ICS dose (daily budesonide eq.) 
0 (0-1600) 
400 (0-2400) 
0.13 

Required burst of OCS (%) 
80 
71 
0.33 

Were admitted (%) 
68 
59 
0.38 

ACQ 
3.1 (1.2) 
3.1 (1.5) 
0.94 

FEV1 %pred. 
77.9 (21.9) 
80.3 (16.7) 
0.57 

FVC %pred. 
84.0 (20.3) 
89.0 (14.1) 
0.20 

Beta-2-agonist within 8 hours? (%) 
52 
42 
0.32 

FeNO (ppb) a 

35 (26-46) 
28 (22-34) 
0.21 

Blood eosinophils (×10 9 </table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Respir Med. Author manuscript; available in PMC 2018 February 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>The study was in part funded by unrestricted grants from The Lundbeck Foundation (Grant/Award Number: R140-2013-13394) and Norpharma A/S.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Global Initiative for Asthma (GINA) Program. GINA Guideline</title>
		<imprint>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Respiratory viruses and exacerbations of asthma in adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">G</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Ireland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="issue">6910</biblScope>
			<biblScope unit="page" from="982" to="988" />
			<date type="published" when="1993-10-16" />
		</imprint>
	</monogr>
	<note>PubMed: 8241910</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Non-eosinophilic asthma: importance and possible mechanisms</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Douwes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Pekkanen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Pearce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax. BMJ Group</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="643" to="651" />
			<date type="published" when="2002-07" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The relationship between airways inflammation and asthma severity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Louis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">O</forename><surname>Bron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Roldaan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Radermecker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Djukanović</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="9" to="16" />
			<date type="published" when="2000-01" />
		</imprint>
	</monogr>
	<note>PubMed: 10619791</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Association between neutrophilic airway inflammation and airflow limitation in adults with asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hargadon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Shelley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Green</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007-12" />
			<publisher>American College of Chest Physicians</publisher>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="1871" to="1876" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Frequent exacerbators-a distinct phenotype of severe asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kupczyk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Brinke Ten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Sterk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">H</forename><surname>Bel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Papi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Chanez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="212" to="233" />
			<date type="published" when="2014-02" />
		</imprint>
	</monogr>
	<note>PubMed: 24447083</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kouzaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>O&amp;apos;grady</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">B</forename><surname>Lawrence</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1427" to="1461" />
			<date type="published" when="2009" />
			<publisher>American Association of Immunologists</publisher>
		</imprint>
	</monogr>
	<note>Jul</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Uller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Leino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Bedke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Sammut</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Lau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="626" to="658" />
			<date type="published" when="2010-07" />
		</imprint>
	</monogr>
	<note>PubMed: 20627922</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Soumelis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">A</forename><surname>Reche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kanzler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Edward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Homey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="673" to="80" />
			<date type="published" when="2002-07" />
		</imprint>
	</monogr>
	<note>PubMed: 12055625</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mjösberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bernink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Golebski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Karrich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">P</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Blom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="649" to="59" />
			<date type="published" when="2012-10-19" />
		</imprint>
	</monogr>
	<note>PubMed: 23063330</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>O&amp;apos;connor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ratoff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Cousins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">181</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2790" to="2798" />
			<date type="published" when="2008-08-15" />
		</imprint>
	</monogr>
	<note>PubMed: 18684970</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Gauvreau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>O&amp;apos;byrne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L-P</forename><surname>Boulet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Cockcroft</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bigler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">370</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="2102" to="2112" />
			<date type="published" when="2014-05-29" />
		</imprint>
	</monogr>
	<note>PubMed: 24846652</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Message</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Laza-Stanca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Mallia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kebadze</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">36</biblScope>
			<biblScope unit="page" from="13562" to="13569" />
			<date type="published" when="2008-09" />
		</imprint>
	</monogr>
	<note>PubMed: 18768794</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Makrinioti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bmj</forename><surname>Rana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bwh</forename><surname>Shamji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-B</forename><surname>Trujillo-Torralbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Footitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1373" to="82" />
			<date type="published" when="2014-12-15" />
		</imprint>
	</monogr>
	<note>PubMed: 25350863</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Role of deficient type III interferon-λ production in asthma exacerbations</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Contoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">D</forename><surname>Message</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Laza-Stanca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pab</forename><surname>Wark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">W</forename><surname>Bartlett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1023" to="1029" />
			<date type="published" when="2006-08-13" />
		</imprint>
	</monogr>
	<note>PubMed: 16906156</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Counterregulation between the Fc RI Pathway and Antiviral Responses in Human Plasmacytoid Dendritic Cells. The Journal of Immunology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bajwa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">I</forename><surname>Dougherty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Jiang</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010-05-18" />
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="5999" to="6006" />
		</imprint>
	</monogr>
	<note>PubMed: 20410486</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Durrani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Montville</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Pratt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Sahu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">K</forename><surname>Devries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Rajamanickam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="489" to="95" />
			<date type="published" when="2012-08" />
		</imprint>
	</monogr>
	<note>PubMed: 22766097</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Contoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Padovani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Poletti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Marku</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="910" to="930" />
			<date type="published" when="2015-08" />
		</imprint>
	</monogr>
	<note>PubMed: 25858686</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">K</forename><surname>Reddel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Bateman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L-P</forename><surname>Boulet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">A</forename><surname>Boushey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">W</forename><surname>Busse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Respiratory and Critical Care Medicine</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="59" to="99" />
			<date type="published" when="2009" />
			<publisher>American Thoracic Society</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19535666</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide</title>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="912" to="942" />
			<date type="published" when="2005-04-15" />
			<publisher>European Respiratory Society</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 15817806</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Standardisation of spirometry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hankinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Brusasco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Burgos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Casaburi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Coates</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="319" to="357" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
	<note>PubMed: 16055882</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Hankinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Odencrantz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">B</forename><surname>Fedan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1999-01" />
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="179" to="87" />
		</imprint>
	</monogr>
	<note>PubMed: 9872837</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The use of induced sputum to investigate airway inflammation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">D</forename><surname>Pavord</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Pizzichini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Pizzichini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">E</forename><surname>Hargreave</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="498" to="501" />
			<date type="published" when="1997-06" />
		</imprint>
	</monogr>
	<note>PubMed: 9227713</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Development and validation of a questionnaire to measure asthma control</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">F</forename><surname>Juniper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>O&amp;apos;byrne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Ferrie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>King</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="902" to="909" />
			<date type="published" when="1999-10" />
		</imprint>
	</monogr>
	<note>PubMed: 10573240</note>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">An economical tandem multiplex real-time PCR technique for the detection of a comprehensive range of respiratory pathogens. Viruses. Molecular Diversity Preservation International</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename><surname>Chidlow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">B</forename><surname>Harnett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename><surname>Shellam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Smith</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009-06" />
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="42" to="56" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Respiratory viral pathogens associated with lower respiratory tract disease among young children in the highlands of Papua New Guinea</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">R</forename><surname>Chidlow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">A</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">B</forename><surname>Harnett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Greenhill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Phuanukoonnon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Siba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="235" to="244" />
			<date type="published" when="2012-07" />
		</imprint>
	</monogr>
	<note>PubMed: 22595309</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Improved molecular typing assay for rhinovirus species A, B, and C</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">A</forename><surname>Bochkov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Grindle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Vang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Gern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Microbiology</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2461" to="71" />
			<date type="published" when="2014-07" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W-M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kiesner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Pappas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Grindle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Jartti</surname></persName>
		</author>
		<idno>e966.</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">10</biblScope>
			<date type="published" when="2007" />
		</imprint>
	</monogr>
	<note>PubMed: 17912345</note>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title level="m" type="main">Manual of Clinical Microbiology, Chapter 18</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Pfaller</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015" />
			<biblScope unit="page">1</biblScope>
		</imprint>
	</monogr>
	<note>Amer Society for Microbiology</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Inflammatory subtypes in asthma: assessment and identification using induced sputum</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respirology. Blackwell Science Pty</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="54" to="61" />
			<date type="published" when="2006-01" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Shikotra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">F</forename><surname>Choy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Ohri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Doran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Butler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hargadon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="104" to="115" />
			<date type="published" when="2012-01" />
		</imprint>
	</monogr>
	<note>PubMed: 21975173</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">B</forename><surname>Headley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y-M</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Berlin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Debley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1187" to="1196" />
			<date type="published" when="2012-11" />
		</imprint>
	</monogr>
	<note>PubMed: 22981788</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">S</forename><surname>Woolhouse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Bayley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Stockley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax. BMJ Group</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="667" to="71" />
			<date type="published" when="2002-08" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Custovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Sanderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Woodcock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="issue">7340</biblScope>
			<biblScope unit="page">763</biblScope>
			<date type="published" when="2002-03-30" />
		</imprint>
	</monogr>
	<note>PubMed: 11923159</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Hanania</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Noonan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Corren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Korenblat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Fischer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="70" to="2014" />
			<date type="published" when="1922" />
			<publisher>BMJ Publishing Group Ltd and British Thoracic Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Dupilumab in persistent asthma with elevated eosinophil levels</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Pearlman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Spector</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Sher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Skobieranda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="2455" to="66" />
			<date type="published" when="2013-06-27" />
		</imprint>
	</monogr>
	<note>PubMed: 23688323</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Mepolizumab treatment in patients with severe eosinophilic asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">G</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">D</forename><surname>Pavord</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">G</forename><surname>Brusselle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Chetta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1198" to="207" />
			<date type="published" when="2014-09-25" />
		</imprint>
	</monogr>
	<note>PubMed: 25199059</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">D</forename><surname>Pavord</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Korn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Howarth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">R</forename><surname>Bleecker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Buhl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">N</forename><surname>Keene</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9842</biblScope>
			<biblScope unit="page" from="651" to="660" />
			<date type="published" when="2012-08-18" />
		</imprint>
	</monogr>
	<note>PubMed: 22901886</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Lower Airway Rhinovirus Burden and the Seasonal Risk of Asthma Exacerbation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Denlinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Sorkness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W-M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Wolff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Mathur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1007" to="1021" />
			<date type="published" when="2011-11" />
		</imprint>
	</monogr>
	<note>PubMed: 21816938</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pab</forename><surname>Wark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Moric</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Hensley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Gibson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="68" to="75" />
			<date type="published" when="2002-01" />
		</imprint>
	</monogr>
	<note>PubMed: 11852895</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Association between human rhinovirus C and severity of acute asthma in children</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bizzintino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">A</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Vang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Pappas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Respiratory Journal</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1037" to="1079" />
			<date type="published" when="2011-04-30" />
		</imprint>
	</monogr>
	<note>PubMed: 20693244</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Severity of rhinovirus infection in hospitalized adults is unrelated to genotype</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Mcculloch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Sears</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Jacob</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Lyon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">M</forename><surname>Burd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Caliendo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Pathol</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="165" to="72" />
			<date type="published" when="2014-08" />
			<publisher>The Oxford University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pab</forename><surname>Wark</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Tooze</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Parsons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respirology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="996" to="1002" />
			<date type="published" when="2013-08" />
		</imprint>
	</monogr>
	<note>PubMed: 23600594</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
